54 results match your criteria: "Centre de compétence maladies orphelines pulmonaires[Affiliation]"

Combined pulmonary fibrosis and emphysema in systemic sclerosis: A syndrome associated with heavy morbidity and mortality.

Semin Arthritis Rheum

August 2019

Department of Internal Medicine, Service de Médecine Interne, Hôpital Cochin, Centre de Référence Maladies Systémiques Autoimmunes Rares d'Ile de France, DHU Authors (Autoimmune and Hormonal Diseases), Université Paris Descartes, Assistance Publique-Hôpitaux de Paris (AP-HP), 27, rue du Faubourg Saint-Jacques, 75679 Paris Cedex 14, France. Electronic address:

Background: The syndrome of combined pulmonary fibrosis and emphysema (CPFE) primarily due to tobacco smoking has been reported in connective tissue disease, but little is known about its characteristics in systemic sclerosis (SSc).

Methods: In this retrospective multi-center case-control study, we identified 36 SSc patients with CPFE, and compared them with 72 SSc controls with interstitial lung disease (ILD) without emphysema.

Results: Rate of CPFE in SSc patients with CT scan was 3.

View Article and Find Full Text PDF

Pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia: Correlations between computed tomography findings and cerebral complications.

Eur Radiol

March 2018

Hospices Civils de Lyon, Hôpital Cardiologique Louis Pradel, Département d'Imagerie Cardiaque et Thoracique, Diagnostique et Interventionnelle, 59 Boulevard Pinel, 69500, Bron, France.

Objectives: Computed tomography (CT) is the modality of choice to characterise pulmonary arteriovenous malformations (PAVMs) in patients with hereditary haemorrhagic telangiectasia (HHT). Our objective was to determine if CT findings were associated with frequency of brain abscess and ischaemic stroke.

Methods: This retrospective study included patients with HHT-related PAVMs.

View Article and Find Full Text PDF

Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus: Results From the French Pulmonary Hypertension Registry.

Chest

January 2018

Université Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre; AP-HP, Centre de reference de l'Hypertension Pulmonaire, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre; INSERM UMR_S999, LabEx LERMIT, Centre Chirurgical Marie-Lannelongue, Le Plessis-Robinson, France.

Background: Pulmonary arterial hypertension (PAH) is a rare complication of systemic lupus erythematosus (SLE).

Methods: We identified all patients with SLE and PAH (SLE-PAH) who were enrolled in the French Pulmonary Hypertension Registry with a diagnosis confirmed by right heart catheterization (RHC). A control group of 101 patients with SLE without known PAH was selected from SLE expert centers participating in the Pulmonary Hypertension Registry.

View Article and Find Full Text PDF

Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

Eur Respir J

November 2016

Hospices civils de Lyon, Hôpital Louis Pradel, Service de pneumologie - centre de référence des maladies orphelines pulmonaires; Université de Lyon, Université Lyon I; UCBL-INRA-ENVL-EPHE, UMR754; IFR128; Lyon, France.

The respiratory manifestations of eosinophilic granulomatosis with polyangiitis (EGPA) have not been studied in detail.In this retrospective multicentre study, EGPA was defined by asthma, eosinophilia and at least one new onset extra-bronchopulmonary organ manifestation of disease.The study population included 157 patients (mean±sd age 49.

View Article and Find Full Text PDF

Objective: Coexistence of ANCA-associated vasculitis (AAV) and IBD is a rare condition that is rarely described in the literature. The aim of the study was to describe the main characteristics of patients presenting with both IBD and AAV.

Methods: A retrospective study of AAV patients in the French Vasculitis Study Group cohort who also had a diagnosis of IBD was conducted.

View Article and Find Full Text PDF

Home-based pulmonary rehabilitation in idiopathic pulmonary fibrosis.

Rev Mal Respir

September 2011

Service de pneumologie et immuno-allergologie, centre de compétence maladies orphelines pulmonaires, clinique des maladies respiratoires, hôpital A.-Calmette, CHRU, boulevard du Pr-Leclercq, 59037 Lille cedex, France.

Introduction: Idiopathic pulmonary fibrosis (IPF) is a severe chronic lung disease. Pulmonary rehabilitation could improve the quality of life of patients with this condition.

Methods: We prospectively evaluated the impact of an 8-week home-based pulmonary rehabilitation programme over 10 months in stable patients suffering from IPF.

View Article and Find Full Text PDF

Effects of oxygen on exercise-induced increase of pulmonary arterial pressure in idiopathic pulmonary fibrosis.

Sarcoidosis Vasc Diffuse Lung Dis

December 2008

Clinique des Maladies Respiratoires, Centre de Compétence Maladies Orphelines Pulmonaires, University Hospital, CHRU, Lille, France.

Introduction: Idiopathic pulmonary fibrosis (IPF) is a severe disease with no known effective therapy. Patients with IPF may develop severe increase of pulmonary arterial pressure (PAP) on exercise, the mechanisms of which is not clearly identified.

Objectives: To determine whether oxygen may correct the increase of PAP developed during exercise in patients with IPF.

View Article and Find Full Text PDF

[Home-based pulmonary rehabilitation in idiopathic pulmonary fibrosis].

Rev Mal Respir

March 2009

Clinique des maladies respiratoires, Centre de compétence maladies orphelines pulmonaires, Hôpital Albert-Calmette, CHRU de Lille, France.

Introduction: Idiopathic pulmonary fibrosis (IPF) is a severe chronic lung disease. Pulmonary rehabilitation could improve the quality of life of patients with this condition.

Methods: We prospectively evaluated the impact of an 8 week home-based pulmonary rehabilitation program over 10 months in stable patients suffering from IPF.

View Article and Find Full Text PDF

Background: Hypoxemia is common in pulmonary hypertension (PH) and may be partly related to ventilation/perfusion mismatch, low diffusion capacity, low cardiac output, and/or right-to-left (RL) shunting.

Methods: To determine whether true RL shunting causing hypoxemia is caused by intracardiac shunting, as classically considered, a retrospective single center study was conducted in consecutive patients with precapillary PH, with hypoxemia at rest (PaO2 < 10 kPa), shunt fraction (Qs/Qt) greater than 5%, elevated alveolar-arterial difference of PO2 (AaPO2), and with transthoracic contrast echocardiography performed within 3 months.

Results: Among 263 patients with precapillary PH, 34 patients were included: pulmonary arterial hypertension, 21%; PH associated with lung disease, 47% (chronic obstructive pulmonary disease, 23%; interstitial lung disease, 9%; other, 15%); chronic thromboembolic PH, 26%; miscellaneous causes, 6%.

View Article and Find Full Text PDF

Persistent airflow obstruction in asthma of patients with Churg-Strauss syndrome and long-term follow-up.

Allergy

April 2009

Hospices civils de Lyon, Hôpital Louis Pradel, centre de référence des maladies orphelines pulmonaires, Université de Lyon, UCBL-INRA-ENVL-EPHE, UMR, IFR, France.

Background: Little is known about the long-term outcome of airflow obstruction in asthma of patients with Churg-Strauss syndrome (CSS).

Methods: We conducted a retrospective study of 24 consecutive patients (aged 41.1 +/- 13.

View Article and Find Full Text PDF

[Pulmonary hypertension in chronic respiratory and cardiac diseases].

Rev Prat

November 2008

Service de pneumologie, centre de référence des maladies orphelines pulmonaires, hôpital cardiovasculaire et pneumologique Louis-Pradel, 69677 Lyon Cedex, France.

Pulmonary hypertension (PH) is frequent in the course of chronic respiratory diseases with hypoxia which leads to vascular remodeling, especially chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. PH is usually moderate but may be disproportionate in some patients. In the chronic diseases of the left heart, increased atrial pressure results in pulmonary venous distension and passive PH (post-capillary) which may further lead to precapillary hypertension.

View Article and Find Full Text PDF

[Pulmonary amyloidosis and non-amyloid immunoglobulin deposits].

Rev Mal Respir

June 2008

Hôpital Louis Pradel, Service de Pneumologie, Centre de référence des maladies orphelines pulmonaires, Lyon, France.

The amyloidoses are characterised histopathologically by the tissue deposition of fibrillar amyloid, specifically stained by Congo red and birefringent under polarised light. This characteristic is linked to a beta-folded structural configuration that is the common denominator of the amyloidoses which may have more than twenty distinct protein precursors. The most common is AL amyloidosis which is of immunoglobulin origin.

View Article and Find Full Text PDF

[Severe phenotypes in sarcoidosis pulmonary involvement].

Rev Prat

May 2008

Service de pneumologie et immunoallergologie, centre de compétence des maladies orphelines pulmonaires, clinique des maladies respiratoires, hôpital Albert-Calmette, CHRU de Lille, Université Lille-II, 59037 Lille Cedex, France.

Severe forms of pulmonary sarcoidosis are not frequent and include stage IV pulmonary involvement and specific complications of intrathoracic sarcoidosis. Pulmonary hypertension may be due to granulomatous involvement of vessels and/or extrinsic compression of pulmonary arteries by enlarged lymph nodes. Bronchial stenosis is rare and delay in therapy usually result in corticoresistance.

View Article and Find Full Text PDF

The vasculitides involving the lower respiratory tract are mainly the small vessels vasculitides associated with antineutrophil cytoplasmic autoantibodies including Wegener granulomatosis (WG), microscopic polyangiitis (MPA), and Churg-Strauss syndrome (SCS). WG pulmonary manifestations mainly consist of nodules and pneumonias often cavitary, and tracheobronchial stenoses. MPA often consists of pulmonary-renal syndrome with alveolar hemorrhage possibly severe.

View Article and Find Full Text PDF

[Idiopathic pulmonary fibrosis].

Presse Med

November 2008

Service de Pneumologie, Centre de Référence des Maladies Orphelines Pulmonaires, Hôpital Louis Pradel, Hospices Civils de Lyon, Université Lyon I, UMR 754 INRA ENVL IFR128, Lyon, France.

Idiopathic pulmonary fibrosis is a chronic disorder characterized histopathologically by a pattern of usual interstitial pneumonia, with heterogeneous and mutilating interstitial fibrosis with foci of proliferating fibroblasts, honeycomb lung, and little if any inflammation. The diagnosis is based on a pluridisciplinary analysis of the clinical symptoms, the chest high-resolution computerized tomography features, and pathology on video-thoracoscopic lung biopsy when indicated. In half of the cases, the typical tomodensitometric pattern allows to make a confident diagnosis without a lung biopsy.

View Article and Find Full Text PDF

[Interstitial lung disease in connective tissue diseases].

Rev Prat

December 2007

Service de pneumologie, centre de référence des maladies orphelines pulmonaires), hôpital Louis-Pradel, hospices civils de Lyon, université Lyon-I, université de Lyon, UMR 754 INRA-ENVL-UCBL-IFR128, 69677 Lyon, Bron.

Interstitial lung disease (ILD) may occur in the connective tissue diseases, with a negative impact on survival. The diagnosis of ILD is established by crackles of the lung bases at auscultation, and high resolution computed tomography of the chest demonstrating diffuse opacities predominating in the bases (ground glass opacities, reticular opacities, honeycombing, and traction bronchiectases). Bronchoalveolar lavage mostly contributes to the differential diagnosis.

View Article and Find Full Text PDF

[Idiopathic pulmonary fibrosis].

Rev Prat

December 2007

Service de pneumologie, centre de réf6érence des maladies orphelines pulmonaires, hôpital cardiovasculaire et pneumologique Louis-Pradel, université Lyon-1, université de Lyon, 69677 Lyon, Bron.

Idiopathic pulmonary fibrosis (IPF) is currently defined by a set of histopathological-radiological-clinical criteria including an histopathological pattern of usual interstitial pneumonia, reticular opacities with honeycombing at tomodensitometry, progressive exercise dyspnea in a patient older than 60 years with fine crackles at lung bases at auscultation. The incidence of IPF is increasing. Risk factors for the disease have been identified (smoking, exposure to various dusts, genetic polymorphism) but the true cause of FPI remains unknown.

View Article and Find Full Text PDF

[Interstitial lung disease. More accurate diagnosis and an uncertain prognosis].

Rev Prat

December 2007

Service de pneumologie, centre de référence des maladies orphelines pulmonaires, hôpital cardiovasculaire et pneumologie Louis-Pradel, université Lyon-I, université de Lyon, 69677 Lyon, Bron.

View Article and Find Full Text PDF

[Unusual pulmonary presentation of systemic Langerhans cell histiocytosis].

Rev Med Interne

August 2008

Service de pneumologie, centre de référence des maladies orphelines pulmonaires, hôpital L.-Pradel, université Lyon-1, 28, avenue Lépine, 69677 Lyon, France.

An 80-year-old nonsmoking man was referred to our hospital with bilateral perihilar pulmonary opacities. He had a history of epilepsy, sclerosing cholangitis, cutaneous lesions previously diagnosed as localised Langerhans cell histiocytosis. Symptoms included dry cough and dyspnea.

View Article and Find Full Text PDF

[Evidence based respiratory medicine. 6th update workshop of SPLF March 30th, 2007. Interstitial lung diseases].

Rev Mal Respir

November 2007

Hospices Civils de Lyon, Hôpital Louis Pradel, Service de Pneumologie et Centre de Référence des Maladies Orphelines Pulmonaires, Université Lyon 1, UMR 754 INRA-UCBL-ENVL, Lyon, France.

View Article and Find Full Text PDF

[Saddle nose deformity].

Rev Prat

November 2007

Centre de référence des maladies orphelines pulmonaires, hôpital Louis-Pradel, université de Lyon, 69677 Bron.

View Article and Find Full Text PDF

[Pulmonary MALT lymphoma].

Rev Prat

October 2007

Centre de référence des maladies orphelines pulmonaires, hôpital Louis-Pradel, université de Lyon, 69677 Lyon, Bron.

View Article and Find Full Text PDF

[Hypereosinophilic asthma].

Presse Med

January 2008

Service de pneumologie, Centre de référence des maladies orphelines pulmonaires, Hôpital Louis Pradel, F-69677 Bron Cedex, France.

Although moderate airway infiltration by eosinophils is present in the eosinophilic inflammatory phenotype of asthma, hypereosinophilic asthma differs in its frankly elevated levels of eosinophils in the blood, induced sputum, and bronchoalveolar lavage. Some etiologic pitfalls may be tricky especially wheezing in eosinophilic pneumonia induced by drugs or parasitic infections. Idiopathic chronic eosinophilic pneumonia is associated with asthma in most cases.

View Article and Find Full Text PDF